Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
ConvaTec ( (GB:CTEC) ) just unveiled an announcement.
ConvaTec Group PLC has executed a share buyback program, purchasing 1,454,288 ordinary shares at prices ranging from 236.00 to 238.40 pence per share. This buyback is part of a previously announced $300 million program, with the acquired shares held in treasury. The move is likely to impact the company’s financial structure by reducing the number of shares in circulation, potentially increasing shareholder value.
The most recent analyst rating on (GB:CTEC) stock is a Buy with a £3.25 price target. To see the full list of analyst forecasts on ConvaTec stock, see the GB:CTEC Stock Forecast page.
Spark’s Take on GB:CTEC Stock
According to Spark, TipRanks’ AI Analyst, GB:CTEC is a Outperform.
ConvaTec’s overall stock score is driven primarily by its strong financial performance, characterized by consistent revenue growth and solid profitability. Technical analysis indicates a moderate upward trend, although valuation metrics suggest the stock may be overvalued. The absence of earnings call insights and corporate events limits additional context.
To see Spark’s full report on GB:CTEC stock, click here.
More about ConvaTec
ConvaTec Group PLC operates in the medical products industry, focusing on providing advanced wound care, ostomy care, continence and critical care, and infusion care products. The company serves healthcare professionals and patients globally, aiming to improve the lives of people with chronic conditions.
Average Trading Volume: 7,794,706
Technical Sentiment Signal: Hold
Current Market Cap: £4.64B
See more data about CTEC stock on TipRanks’ Stock Analysis page.